Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -274,100 | 9,000 | -760,500 | -711,000 | -447,600 |
| Depreciation Amortization | 68,300 | 34,800 | 364,600 | 329,300 | 77,400 |
| Income taxes - deferred | -12,400 | -12,200 | -8,900 | -3,700 | -6,400 |
| Accounts receivable | -29,600 | -50,000 | -21,600 | -58,500 | -129,800 |
| Accounts payable and accrued liabilities | 200 | -2,400 | 10,600 | 17,700 | 10,900 |
| Other Working Capital | 106,500 | -98,700 | -75,100 | -116,800 | -181,300 |
| Other Operating Activity | 126,000 | 56,900 | 284,600 | 304,600 | 378,400 |
| Operating Cash Flow | $-15,100 | $-62,600 | $-206,300 | $-238,400 | $-298,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,400 | -10,800 | -51,600 | -40,200 | -27,600 |
| Net Acquisitions | N/A | N/A | 270,200 | 270,200 | 270,200 |
| Other Investing Activity | 0 | 0 | -6,300 | -6,300 | 0 |
| Investing Cash Flow | $-15,400 | $-10,800 | $212,300 | $223,700 | $242,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 65,000 | 50,000 | 20,000 | 0 | 0 |
| Debt Repayment | -69,400 | -8,900 | -563,400 | -547,500 | -504,600 |
| Other Financing Activity | -5,800 | -400 | 7,700 | 7,100 | 7,200 |
| Financing Cash Flow | $-10,200 | $40,700 | $-535,700 | $-540,400 | $-497,400 |
| Exchange Rate Effect | 0 | N/A | -1,200 | 300 | -800 |
| Beginning Cash Position | 111,700 | 111,700 | 642,600 | 642,600 | 642,600 |
| End Cash Position | 71,000 | 79,000 | 111,700 | 87,800 | 88,600 |
| Net Cash Flow | $-40,700 | $-32,700 | $-530,900 | $-554,800 | $-554,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,100 | -62,600 | -206,300 | -238,400 | -298,400 |
| Capital Expenditure | -15,400 | -10,800 | -51,600 | -40,200 | -27,600 |
| Free Cash Flow | -30,500 | -73,400 | -257,900 | -278,600 | -326,000 |